Eagle Pharmaceuticals, Inc. (EGRX)
USD 1.7
(13.0%)
USD 1.7
(13.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 30.79 Million | 50.7 Million | 28.21 Million | 49.49 Million | 55.98 Million | 52.38 Million |
| Net Income | -2.66 Million | 35.64 Million | -8.62 Million | 11.98 Million | 14.31 Million | 31.9 Million |
| Depreciation & Amortization | 16.66 Million | 12.02 Million | 3.76 Million | 4.76 Million | 4.65 Million | 3.67 Million |
| Deferred income taxes | 29.93 Million | -8.32 Million | -3.61 Million | -1.51 Million | 152 Thousand | -2.46 Million |
| Stock-based compensation | - | 16.45 Million | 19.55 Million | 24.75 Million | 21.99 Million | 19.08 Million |
| Change in working capital | 866 Thousand | -16.4 Million | 9.53 Million | 816 Thousand | 14.39 Million | -7.88 Million |
| Other non-cash items | -30.79 Million | 11.31 Million | 7.61 Million | 8.68 Million | 480 Thousand | 8.08 Million |
| Investing Cash Flow | - | -86.83 Million | -5.32 Million | -18.24 Million | -777 Thousand | -133 Thousand |
| Investments in PPE | - | -178 Thousand | -323 Thousand | -747 Thousand | -777 Thousand | -133 Thousand |
| Acquisitions | - | -74.15 Million | - | - | - | - |
| Investment purchases | - | -12.5 Million | - | -17.5 Million | - | - |
| Sales/Maturities of investments | - | 74.15 Million | - | - | - | - |
| Other Investing Activities | - | -74.15 Million | -5 Million | -17.5 Million | - | - |
| Financing Cash Flow | - | -6.2 Million | -28.39 Million | -37.87 Million | -24.22 Million | -88.11 Million |
| Debt repayment | - | -67.23 Million | -8 Million | -115 Million | -6 Million | -3.75 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -18 Million | -21.21 Million | -34.99 Million | -17.96 Million | -73.1 Million |
| Common Stock Issuance | - | 1.74 Million | 2.39 Million | 3.65 Million | 260 Thousand | 8.61 Million |
| Other Financing Activities | - | 79.03 Million | 821 Thousand | 112.12 Million | -264 Thousand | -11.26 Million |
| Accounts receivables | - | -30.83 Million | 9.52 Million | -3.11 Million | 18.48 Million | -12.66 Million |
| Accounts payables | - | 2.96 Million | 10.16 Million | 806 Thousand | -4.45 Million | -2.06 Million |
| Inventory | 866 Thousand | -8.33 Million | -13.83 Million | -1.5 Million | 1.73 Million | -5.55 Million |
| Other working capital | -866 Thousand | 19.8 Million | 3.67 Million | 4.63 Million | -1.37 Million | 12.39 Million |
| Cash at beginning of period | - | 97.65 Million | 103.15 Million | 109.77 Million | 78.79 Million | 114.65 Million |
| Cash at end of period | 30.79 Million | 55.32 Million | 97.65 Million | 103.15 Million | 109.77 Million | 78.79 Million |
| Capital Expenditure | - | -178 Thousand | -323 Thousand | -747 Thousand | -777 Thousand | -133 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 30.79 Million | -42.33 Million | -5.49 Million | -6.62 Million | 30.98 Million | -35.86 Million |
| Free Cash Flow | 30.79 Million | 50.52 Million | 27.89 Million | 48.75 Million | 55.2 Million | 52.25 Million |
| Breakdown | 2023 Q2 | 2023 FY | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.16 Million | -2.66 Million | 5.75 Million | 35.64 Million | 8.16 Million | -3.51 Million |
| Depreciation & Amortization | 5.58 Million | 16.66 Million | 5.56 Million | 12.02 Million | 5.63 Million | 3.85 Million |
| Deferred income taxes | -1.78 Million | 29.93 Million | -2.18 Million | -8.32 Million | -3.58 Million | -298 Thousand |
| Stock-based compensation | 4.19 Million | - | 4.63 Million | 16.45 Million | 4.11 Million | 3.53 Million |
| Change in working capital | -14.23 Million | 866 Thousand | -48.05 Million | -16.4 Million | 29.1 Million | -24.46 Million |
| Other non-cash items | 954 Thousand | -30.79 Million | 772 Thousand | 11.31 Million | -5.88 Million | 7.64 Million |
| Investing Cash Flow | -6000.00 | - | -12.55 Million | -86.83 Million | -9000.00 | -11.23 Million |
| Investments in PPE | -6000.00 | - | -58 Thousand | -178 Thousand | -10 Thousand | - |
| Acquisitions | - | - | - | -74.15 Million | 1000.00 | 1.26 Million |
| Investment purchases | - | - | -12.5 Million | -12.5 Million | -12.5 Million | -12.5 Million |
| Sales/Maturities of investments | - | - | - | 74.15 Million | - | - |
| Other Investing Activities | - | - | -12.5 Million | -74.15 Million | 12.5 Million | -12.5 Million |
| Financing Cash Flow | -6.41 Million | - | 12.64 Million | -6.2 Million | 2.38 Million | 3.29 Million |
| Debt repayment | -21.25 Million | - | -1.25 Million | -67.23 Million | -61.23 Million | -2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -161 Thousand | - | -1.1 Million | -18 Million | -15 Thousand | -9.95 Million |
| Common Stock Issuance | - | - | - | 1.74 Million | - | 247 Thousand |
| Other Financing Activities | 15 Million | - | 15 Million | 79.03 Million | 63.64 Million | 15.24 Million |
| Accounts receivables | -186 Thousand | - | -42.51 Million | -30.83 Million | 24.49 Million | -11.01 Million |
| Accounts payables | -1.26 Million | - | -1.88 Million | 2.96 Million | 6.79 Million | -6.75 Million |
| Inventory | 922 Thousand | 866 Thousand | 3.65 Million | -8.33 Million | 6.66 Million | -6.14 Million |
| Other working capital | -13.7 Million | -866 Thousand | -7.3 Million | 19.8 Million | -8.84 Million | -548 Thousand |
| Cash at beginning of period | 21.89 Million | - | 55.32 Million | 97.65 Million | 15.38 Million | 36.56 Million |
| Cash at end of period | 15.35 Million | 30.79 Million | 21.89 Million | 55.32 Million | 55.32 Million | 15.38 Million |
| Capital Expenditure | -6000.00 | - | -58 Thousand | -178 Thousand | -10 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.54 Million | 30.79 Million | -33.42 Million | -42.33 Million | 39.93 Million | -21.17 Million |
| Free Cash Flow | -132 Thousand | 30.79 Million | -33.57 Million | 50.52 Million | 37.54 Million | -13.23 Million |
600658
TINNARUBR
002224
PTNUF
TXGN
DORE